Try
HAEMONETICS CORP
HAEUnited States
102 filed reports · 674 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
102 reports · Mar 2013 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 536 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 48 | 518 | Mar 2013 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 40 | 6,488 | Jun 2013 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 14 | 8,333 | Mar 2013 to Mar 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2027 Q1 | 10-Q | Jun 27, 2026 | Aug 6, 2026 | 363 | Open |
| FY2027 Q1 | 8-K | Jun 27, 2026 | Aug 6, 2026 | 6 | Open |
| FY2026 | 10-K | Mar 28, 2026 | May 20, 2026 | 1,186 | Open |
| FY2026 Q4 | 8-K | Mar 28, 2026 | May 7, 2026 | 8 | Open |
| FY2026 Q3 | 10-Q | Dec 27, 2025 | Feb 5, 2026 | 292 | Open |
| FY2026 Q3 | 8-K | Dec 27, 2025 | Feb 5, 2026 | 12 | Open |
| FY2026 Q2 | 10-Q | Sep 27, 2025 | Nov 6, 2025 | 246 | Open |
| FY2026 Q2 | 8-K | Sep 27, 2025 | Nov 6, 2025 | 12 | Open |
| FY2026 Q1 | 10-Q | Jun 28, 2025 | Aug 7, 2025 | 175 | Open |
| FY2026 Q1 | 8-K | Jun 28, 2025 | Aug 7, 2025 | 12 | Open |
| FY2025 | 10-K | Mar 29, 2025 | May 21, 2025 | 556 | Open |
| FY2025 Q4 | 8-K | Mar 29, 2025 | May 8, 2025 | 12 | Open |
Financial data
674 concepts · 15,339 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial614 concepts · 12,964 facts · Apr 2011 to Jul 2026
- Gross profit (US GAAP)77 · Apr 2011 to Jun 2026
- Net income loss77 · Apr 2011 to Jun 2026
- Operating income loss77 · Apr 2011 to Jun 2026
- Revenue77 · Apr 2011 to Jun 2026
- Cash and cash equivalents at carrying value75 · Apr 2011 to Jun 2026
- Restructuring reserve74 · Apr 2011 to Jun 2026
- Comprehensive income net of tax73 · Apr 2011 to Jun 2026
- Depreciation and amortization73 · Apr 2011 to Jun 2026
- Employee stock ownership plan ESOP cash contributions to ESOP73 · Apr 2011 to Jun 2026
- Income tax expense benefit73 · Apr 2011 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities73 · Apr 2011 to Jun 2026
- Increase decrease in accounts receivable73 · Apr 2011 to Jun 2026
- Increase decrease in inventories73 · Apr 2011 to Jun 2026
- Increase decrease in other operating capital net73 · Apr 2011 to Jun 2026
- Increase decrease in prepaid taxes73 · Apr 2011 to Jun 2026
- Net cash provided by used in financing activities73 · Apr 2011 to Jun 2026
- Net cash provided by used in investing activities73 · Apr 2011 to Jun 2026
- Net cash provided by used in operating activities73 · Apr 2011 to Jun 2026
- Operating expenses (US GAAP)73 · Apr 2011 to Jun 2026
- Other nonoperating income expense73 · Apr 2011 to Jun 2026
- Payments to acquire property plant and equipment73 · Apr 2011 to Jun 2026
- Proceeds from sale of property plant and equipment73 · Apr 2011 to Jun 2026
- Research and development expense73 · Apr 2011 to Jun 2026
- Selling general and administrative expense73 · Apr 2011 to Jun 2026
Segment23 concepts · 1,190 facts · Apr 2011 to Jun 2026
- Revenue300 · Apr 2011 to Jun 2026
- Restructuring charges154 · Mar 2014 to Jun 2026
- Turnaround costs150 · Mar 2015 to Jun 2026
- Operating income loss120 · Dec 2015 to Jun 2026
- Net Revenues, Before Foreign Exchange Impact96 · Dec 2015 to Mar 2024
- Goodwill58 · Mar 2015 to Jun 2026
- Depreciation and amortization46 · Mar 2014 to Jun 2026
- Goodwill foreign currency translation gain loss46 · Mar 2015 to Jun 2026
- Net revenues before foreign exchange impact32 · Mar 2014 to Apr 2017
- Segment operating income32 · Mar 2014 to Apr 2017
- Operating Income24 · Jun 2020 to Apr 2023
- Plasma18 · Dec 2020 to Mar 2026
- Cost of goods and services sold (US GAAP)16 · Apr 2023 to Jun 2026
- Research and development expense16 · Apr 2023 to Jun 2026
- Selling general and administrative expense16 · Apr 2023 to Jun 2026
- Goodwill transfers14 · Apr 2016 to Dec 2019
- Transformation costs12 · Mar 2014 to Apr 2016
- Goodwill acquired during period10 · Mar 2020 to Mar 2026
- Goodwill purchase accounting adjustments9 · Apr 2022 to Jun 2026
- Goodwill impairment loss8 · Apr 2016 to Apr 2017
- Property plant and equipment transfers and changes8 · Apr 2016 to Mar 2018
- Goodwill written off related to sale of business unit3 · Mar 2020 to Mar 2025
- Impairment of intangible assets finitelived2 · Apr 2016
Guidance27 concepts · 518 facts · May 2013 to Aug 2026
- Revenue Growth Guidance78 · May 2013 to Aug 2026
- EPS (Diluted) Guidance54 · Jul 2013 to Feb 2025
- Free Cash Flow Guidance54 · Jul 2013 to May 2026
- Operating Margin Guidance (Adjusted (non-GAAP))50 · Oct 2013 to Feb 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))46 · Feb 2017 to Feb 2026
- Operating Margin Guidance46 · May 2013 to Feb 2025
- Revenue Growth Guidance (Organic)44 · May 2013 to Aug 2026
- Free Cash Flow Guidance (Excluding restructuring costs)32 · May 2013 to Nov 2023
- Effective Tax Rate Guidance16 · Jul 2013 to Feb 2017
- Revenue Guidance12 · May 2013 to Feb 2017
- Gross Margin Guidance10 · Jul 2013 to Jan 2015
- Capital Expenditures Guidance8 · Jul 2013 to Feb 2018
- Effective Tax Rate Guidance (Adjusted (non-GAAP))8 · May 2013 to Feb 2017
- Operating Income Guidance8 · Jul 2013 to Nov 2014
- EPS (Diluted) Guidance (Adjusted, excluding amortization)6 · May 2013 to Jan 2014
- Gross Margin Guidance (Adjusted (non-GAAP))6 · May 2013 to Jan 2014
- Operating Income Guidance (Adjusted (non-GAAP))6 · May 2013 to Jan 2014
- Revenue Growth Guidance (Organic, constant currency)6 · May 2013 to Jan 2014
- Revenue Growth Guidance (Organic, excluding CSL)6 · Aug 2025 to Feb 2026
- Free Cash Flow Guidance (before restructuring & turnaround expenses; Adjusted (non-GAAP))4 · Feb 2017 to Feb 2019
- Operating Margin Growth Guidance (Adjusted (non-GAAP))4 · May 2026 to Aug 2026
- Revenue Growth Guidance (Constant currency)4 · May 2018 to Feb 2019
- EPS (Diluted) Growth Guidance2 · Jul 2015
- EPS (Diluted) Growth Guidance (Adjusted, excluding amortization)2 · May 2013
Geography4 concepts · 372 facts · Apr 2011 to Jun 2026
- Revenue346 · Apr 2011 to Jun 2026
- Total Assets24 · Mar 2012 to Mar 2015
- Defined benefit plan net periodic benefit cost1 · Mar 2012
- Foreign Exchange Contract1 · Jun 2013
Product6 concepts · 295 facts · Mar 2013 to Mar 2026
- Revenue269 · Mar 2013 to Mar 2026
- Net Revenues, Before Foreign Exchange Impact11 · Jun 2018 to Oct 2021
- Plasma10 · Dec 2020 to Dec 2023
- Loss contingency loss in period2 · Jun 2013 to Mar 2018
- Revenue from contract with customer including assessed tax2 · Apr 2022 to Apr 2023
- Revenue (including assessed tax)1 · Mar 2024
Segments
1,857 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments31 members · 1,190 facts
- Plasma283 · Jun 2018 to Mar 2026
- Reportable Segments143 · Apr 2011 to Mar 2014
- EMEA123 · Mar 2014 to Mar 2020
- North America Plasma121 · Mar 2014 to Apr 2021
- JP120 · Mar 2014 to Mar 2020
- All Other Segments72 · Mar 2014 to Mar 2026
- Americas Blood Centerand Hospitaland Asia Pacific62 · Mar 2014 to Apr 2021
- Corporate24 · Oct 2022 to Jun 2026
- Apheresis22 · Jun 2025 to Jun 2026
- Apheresis Blood Center22 · Apr 2022 to Mar 2026
- Plasma22 · Mar 2019 to Mar 2026
- Hemostasis Management Hospital22 · Apr 2022 to Mar 2026
- Med Surg22 · Jun 2025 to Jun 2026
- Whole Blood Blood Center22 · Apr 2022 to Mar 2026
- Interventional Technologies Hospital19 · Apr 2022 to Mar 2026
- Blood center15 · Jun 2020 to Apr 2023
- Hospital15 · Jun 2020 to Apr 2023
- Business Unit11 · Apr 2022 to Mar 2024
- Other Hopsital11 · Apr 2022 to Mar 2024
- Jp6 · Mar 2015 to Mar 2020
- North america plasma6 · Mar 2015 to Mar 2020
- Emea6 · Mar 2015 to Mar 2020
- All other segments5 · Mar 2015 to Mar 2019
- Vascular Closure Hosptial4 · Jul 2022 to Sep 2023
- Americas blood centerand hospital3 · Dec 2015 to Apr 2016
- Americas Blood Centerand Hospital2 · Apr 2016 to Apr 2017
- Apheresis2 · Mar 2026 to Jun 2026
- Med surg2 · Mar 2026 to Jun 2026
- Former Europe APA Cand Japan1 · Dec 2019
- Former North America1 · Dec 2019
- Other Countryor Region1 · Apr 2016
Statement geographicalsrt:StatementGeographicalAxis5 members · 235 facts
- Asia47 · Apr 2017 to Jun 2026
- Europe47 · Apr 2017 to Jun 2026
- JP47 · Apr 2017 to Jun 2026
- Other Countryor Region47 · Apr 2017 to Jun 2026
- US47 · Apr 2017 to Jun 2026
Product or serviceus-gaap:ProductOrServiceAxis17 members · 160 facts
- Blood Center22 · Mar 2013 to Mar 2018
- Cell Processing16 · Mar 2015 to Mar 2018
- Hemostasis Management16 · Mar 2015 to Mar 2018
- Plasma16 · Mar 2015 to Mar 2018
- Diagnostics8 · Mar 2013 to Apr 2016
- Disposables Revenue8 · Mar 2013 to Apr 2016
- Equipment And Other Related8 · Mar 2013 to Apr 2016
- Hospital8 · Mar 2013 to Apr 2016
- Orthopat8 · Mar 2013 to Apr 2016
- Plasma Disposables8 · Mar 2013 to Apr 2016
- Platelet8 · Mar 2013 to Apr 2016
- Red Cell8 · Mar 2013 to Apr 2016
- Software Solutions8 · Mar 2013 to Apr 2016
- Surgical8 · Mar 2013 to Apr 2016
- Whole Blood8 · Mar 2013 to Apr 2016
- Certain Whole Blood Collection Sets1 · Jun 2013
- Customer Claims1 · Mar 2018
Statement geographicalus-gaap:StatementGeographicalAxis17 members · 137 facts
- JP20 · Apr 2011 to Mar 2018
- US20 · Apr 2011 to Mar 2018
- Asia17 · Mar 2014 to Mar 2018
- Europe17 · Mar 2014 to Mar 2018
- Other Countryor Region17 · Mar 2014 to Mar 2018
- Other Asia5 · Apr 2011 to Mar 2015
- Other North America5 · Apr 2011 to Mar 2015
- Total Europe5 · Apr 2011 to Mar 2015
- Total North America5 · Apr 2011 to Mar 2015
- Jp4 · Mar 2012 to Mar 2015
- Us4 · Mar 2012 to Mar 2015
- Other asia4 · Mar 2012 to Mar 2015
- Other north america4 · Mar 2012 to Mar 2015
- Total europe4 · Mar 2012 to Mar 2015
- Total north america4 · Mar 2012 to Mar 2015
- CH1 · Mar 2012
- Foreign Country1 · Jun 2013
Product or servicesrt:ProductOrServiceAxis8 members · 135 facts
- Service38 · Mar 2018 to Mar 2024
- Blood Center Productsand Services18 · Jun 2018 to Mar 2026
- Hospital Productsand Services18 · Jun 2018 to Mar 2026
- Blood Center15 · Apr 2017 to Apr 2023
- Hospital15 · Apr 2017 to Apr 2023
- Plasma15 · Apr 2017 to Apr 2023
- Plasma Productsand Services15 · Jun 2018 to Dec 2022
- Service1 · Mar 2024
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2027 Q1Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.